Comorbidities in patients with alopecia areata - 18/04/17
Doi : 10.1016/j.jaad.2016.12.007
Ruzica Z. Conic, MD a, b, ⁎ 
, Rose Miller, BA a, c, Melissa Piliang, MD a, Wilma Bergfeld, MD a, Natasha Atanaskova Mesinkovska, MD, PhD a, d
, Rose Miller, BA a, c, Melissa Piliang, MD a, Wilma Bergfeld, MD a, Natasha Atanaskova Mesinkovska, MD, PhD a, d a Department of Dermatology and Dermatopathology, Cleveland Clinic Foundation, Ohio
b Department of Dermatology, Case Western Reserve University, Cleveland, Ohio
c Ohio State University College of Medicine, Columbus, Ohio
d Department of Dermatology and Dermatopathology, University of California, Irvine
∗Correspondence to: Ruzica Z. Conic, MD, Department of Dermatology and Dermatopathology, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195.Department of Dermatology and DermatopathologyCleveland Clinic Foundation9500 Euclid AveClevelandOH44195
| Dr Conic and Ms Miller contributed equally to this work. |
|
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Presented at 9th World Congress for Hair Research, Miami, Florida, November 18-21, 2015, and 73rd Annual Meeting of the American Academy of Dermatology, San Francisco, California, March 20-24, 2015. |
© 2016
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 76 - N° 4
P. 755-757 - avril 2017 Retour au numéro
Article précédent
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Leslie Castelo-Soccio
- Can mindfulness-based interventions improve the quality of life of patients with moderate/severe alopecia areata? A prospective pilot study
- Rosella Gallo, Carlo Chiorri, Giulia Gasparini, Alessio Signori, Anna Burroni, Aurora Parodi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?